National Center for Advancing Translational Sciences; Notice of Meetings, 33679 [2016-12500]

Download as PDF Federal Register / Vol. 81, No. 103 / Friday, May 27, 2016 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Advancing Translational Sciences; Notice of Meetings sradovich on DSK3TPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the meeting of the National Center for Advancing Translational Sciences Advisory Council. The meeting will be open as indicated below, viewing virtually by Webex. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy Individuals can register to view and access the meeting by the link below. https://nih.webex.com/nih/onstage/ g.php?MTID=ea58bf69ded 4e3ef172feeb063ee9e4e5. 1. Go to ‘‘Event Status’’ on the left hand side of page, then click ‘‘Register’’. On the registration form, enter your information and then click ‘‘Submit’’ to complete the required registration. 2. You will receive a personalized email with the live event link. Name of Committee: National Center for Advancing Translational Sciences Advisory Council. Date: June 13, 2016. Open: 12:00 p.m. to 2:00 p.m. Agenda: Report from the Institute Director and other staff. Place: National Institutes of Health, NCATS Board Room, 9800 Medical Center Drive, Rockville, MD 20850, (Virtual Meeting). Closed: 2:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, NCATS Board Room, 9800 Medical Center Drive, Rockville, MD 20850, (Virtual Meeting). Contact Person: Anna L. Ramsey-Ewing, Ph.D., Executive Secretary, National Center for Advancing Translational Sciences, 1 Democracy Plaza, Room 1072, Bethesda, MD 20892, 301–435–0809, anna.ramseyewing@ nih.gov. This notice is being published less than 15 days prior to the meeting due to finalizing the agenda and scheduling of meeting topics. Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 VerDate Sep<11>2014 18:00 May 26, 2016 Jkt 238001 U.S.C. App.), notice is hereby given of the meeting of the Cures Acceleration Network Review Board. Name of Committee: Cures Acceleration Network Review Board. Date: June 13, 2016. Time: 12:00 p.m. to 2:00 p.m. Agenda: Report from the Institute Director. Place: National Institutes of Health, NCATS Board Room, 9800 Medical Center Drive, Rockville, MD 20850, (Virtual Meeting). Contact Person: Anna L. Ramsey-Ewing, Ph.D., Executive Secretary, National Center for Advancing Translational Sciences, 1 Democracy Plaza, Room 1072, Bethesda, MD 20892, 301–435–0809, anna.ramseyewing@ nih.gov. This notice is being published less than 15 days prior to the meeting due to finalizing the agenda and scheduling of meeting topics. (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: May 23, 2016. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–12500 Filed 5–26–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Human Genome Research Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Human Genome Research Institute Special Emphasis Panel; ENCODE Characterization. Date: July 7, 2016. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Renaissance Arlington Capital View Hotel, 2800, Studio D, South Potomac Ave., Arlington, VA 22202. Contact Person: Keith McKenney, Ph.D., Scientific Review Officer, NHGRI, 5635 PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 33679 Fishers Lane, Suite 4076, Bethesda, MD 20814, 301–594–4280, mckenneyk@ mail.nih.gov. Name of Committee: National Human Genome Research Institute Special Emphasis Panel; ENCODE DATA. Date: July 14, 2016. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Crystal City Marriott, Need Rom Room, 1999 Jefferson Davis Highway, Arlington, VA 22202. Contact Person: Lita Proctor, Ph.D., Extramural Research Programs Staff, Program Director, Human Microbiome Project, National Human Genome Research Institute, 5635 Fishers Lane, Suite 4076, Bethesda, MD 20892, 301 496–4550, proctorlm@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS) Dated: May 20, 2016. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–12501 Filed 5–26–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Recombinant DNA Advisory Committee. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Recombinant DNA Advisory Committee. Date: June 21–22, 2016. Time: 8:00 a.m. to 5:00 p.m. Agenda: The NIH Recombinant DNA Advisory Committee (RAC) will review and discuss selected human gene transfer protocols and related data management activities. In addition, Dr. Carl June (Perelman School of Medicine, Univ. of Pennsylvania) will present the results of findings of his group regarding a rare Chimeric Antigen Receptor (CAR) T cell manufacturing event. For more information, please check the meeting agenda at the OSP Web site, RAC Meeting Page (available at the following URL: https://osp.od.nih.gov/officebiotechnology-activities/event/2016-06-21120000-2016-06-210000/rac-meeting). E:\FR\FM\27MYN1.SGM 27MYN1

Agencies

[Federal Register Volume 81, Number 103 (Friday, May 27, 2016)]
[Notices]
[Page 33679]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-12500]



[[Page 33679]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the meeting of the 
National Center for Advancing Translational Sciences Advisory Council.
    The meeting will be open as indicated below, viewing virtually by 
Webex.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy
    Individuals can register to view and access the meeting by the link 
below. https://nih.webex.com/nih/onstage/g.php?MTID=ea58bf69ded4e3ef172feeb063ee9e4e5.
    1. Go to ``Event Status'' on the left hand side of page, then click 
``Register''. On the registration form, enter your information and then 
click ``Submit'' to complete the required registration.
    2. You will receive a personalized email with the live event link.

    Name of Committee: National Center for Advancing Translational 
Sciences Advisory Council.
    Date: June 13, 2016.
    Open: 12:00 p.m. to 2:00 p.m.
    Agenda: Report from the Institute Director and other staff.
    Place: National Institutes of Health, NCATS Board Room, 9800 
Medical Center Drive, Rockville, MD 20850, (Virtual Meeting).
    Closed: 2:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, NCATS Board Room, 9800 
Medical Center Drive, Rockville, MD 20850, (Virtual Meeting).
    Contact Person: Anna L. Ramsey-Ewing, Ph.D., Executive 
Secretary, National Center for Advancing Translational Sciences, 1 
Democracy Plaza, Room 1072, Bethesda, MD 20892, 301-435-0809, 
anna.ramseyewing@nih.gov.

    This notice is being published less than 15 days prior to the 
meeting due to finalizing the agenda and scheduling of meeting 
topics.
    Pursuant to section 10(a) of the Federal Advisory Committee Act, 
as amended (5 U.S.C. App.), notice is hereby given of the meeting of 
the Cures Acceleration Network Review Board.
    Name of Committee: Cures Acceleration Network Review Board.
    Date: June 13, 2016.
    Time: 12:00 p.m. to 2:00 p.m.
    Agenda: Report from the Institute Director.
    Place: National Institutes of Health, NCATS Board Room, 9800 
Medical Center Drive, Rockville, MD 20850, (Virtual Meeting).
    Contact Person: Anna L. Ramsey-Ewing, Ph.D., Executive 
Secretary, National Center for Advancing Translational Sciences, 1 
Democracy Plaza, Room 1072, Bethesda, MD 20892, 301-435-0809, 
anna.ramseyewing@nih.gov.

    This notice is being published less than 15 days prior to the 
meeting due to finalizing the agenda and scheduling of meeting 
topics.

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 
Pharmacology, Physiology, and Biological Chemistry Research; 93.350, 
B--Cooperative Agreements; 93.859, Biomedical Research and Research 
Training, National Institutes of Health, HHS)

    Dated: May 23, 2016.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-12500 Filed 5-26-16; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.